Insider trading

Period: 120 months Stock: QURE + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

272 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

272 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

272 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

272 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
272 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
272 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

272 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
30 Jan 2020
Sold, plan not stated
$47.80K 807 at 59.23
11.8%
29 Jan 2020
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 3×
$1.46M 23,583 at 61.94
7.5%
28 Jan 2020
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 3×
$1.46M 23,583 at 61.92
7.0%
28 Jan 2020
KLEMT CHRISTIAN Chief Accounting Officer
Sold, plan not stated 2×
$736.07K 11,975 at 61.47
22.0%
28 Jan 2020
van Deventer Sander EVP, Research & Product Dev.
Sold, plan not stated 2×
$137.21K 2,227 at 61.61
4.9%
28 Jan 2020
Kuta Alexander Edward III Executive VP, Operations
Sold, plan not stated 2×
$91.85K 1,478 at 62.14
3.6%
28 Jan 2020
Sold, plan not stated
$50.20K 807 at 62.20
11.8%
28 Jan 2020
Sold, plan not stated 2×
$50.19K 807 at 62.19
11.8%
28 Jan 2020
SCHAFFER DAVID Director
Sold, plan not stated
$50.19K 806 at 62.27
1.8%
28 Jan 2020
Sold, plan not stated
$50.19K 807 at 62.19
15.1%
28 Jan 2020
Kaye Jack Director
Sold, plan not stated
$50.13K 806 at 62.20
5.4%
28 Jan 2020
Meek David D. Director
Sold, plan not stated 2×
$44.90K 722 at 62.19
22.4%
28 Jan 2020
Gut Robert Chief Medical Officer
Sold, plan not stated
$37.07K 596 at 62.19
2.1%
27 Jan 2020
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 4×
$1.85M 28,289 at 65.55
7.7%
27 Jan 2020
Gut Robert Chief Medical Officer
Sold, plan not stated
$413.89K 6,897 at 60.01
19.5%
15 Jan 2020
Kuta Alexander Edward III Executive VP, Operations
Sold, plan not stated
$275.88K 4,000 at 68.97
8.8%
7 Jan 2020
Sold, plan not stated
$216.54K 3,000 at 72.18
35.9%
18 Dec 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 3×
$528.51K 7,540 at 70.09
2.0%
16 Dec 2019
Kuta Alexander Edward III Executive VP, Operations
Sold, plan not stated 2×
$298.36K 4,000 at 74.59
8.8%
13 Dec 2019
Sold, plan not stated
$141.00K 2,000 at 70.50
19.3%
9 Dec 2019
Sold, plan not stated
$168.75K 2,500 at 67.50
23.0%
6 Dec 2019
Sold, plan not stated 2×
$583.60K 9,082 at 64.26
45.6%
20 Nov 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 3×
$429.95K 8,000 at 53.74
2.1%
15 Nov 2019
Kuta Alexander Edward III Executive VP, Operations
Sold, plan not stated 2×
$208.31K 4,000 at 52.08
8.8%
23 Oct 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 2×
$345.78K 8,000 at 43.22
2.1%
15 Oct 2019
Kuta Alexander Edward III Executive VP, Operations
Sold, plan not stated
$169.40K 4,000 at 42.35
8.8%
19 Sep 2019
Gut Robert Chief Medical Officer
Sold, plan not stated
$224.91K 4,769 at 47.16
11.9%
18 Sep 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 4×
$378.49K 8,000 at 47.31
2.0%
16 Sep 2019
Kuta Alexander Edward III Executive VP, Operations
Sold, plan not stated
$189.04K 4,000 at 47.26
13.1%
21 Aug 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated
$451.84K 8,000 at 56.48
2.0%
1 Aug 2019
Sold, plan not stated 4×
$388.34K 6,460 at 60.12
48.7%
17 Jul 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 4×
$571.62K 8,000 at 71.45
2.0%
19 Jun 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 2×
$619.63K 8,000 at 77.45
1.9%
3 Jun 2019
Sold, plan not stated 4×
$381.78K 6,000 at 63.63
31.1%
15 May 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 3×
$467.02K 8,000 at 58.38
1.9%
16 Apr 2019
KLEMT CHRISTIAN Chief Accounting Officer
Sold, plan not stated
$88.40K 1,546 at 57.18
2.8%
1 Apr 2019
Sold, plan not stated
$359.04K 6,000 at 59.84
23.7%
14 Mar 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 3×
$1.24M 19,688 at 63.09
4.4%
13 Mar 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated 3×
$3.07M 47,688 at 64.32
9.7%
15 Feb 2019
Kuta Alexander Edward III SVP, Regulatory Affairs
Sold, plan not stated 2×
$286.56K 8,000 at 35.82
17.2%
28 Jan 2019
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated
$599.65K 19,085 at 31.42
3.7%
28 Jan 2019
KLEMT CHRISTIAN Chief Accounting Officer
Sold, plan not stated
$46.28K 1,479 at 31.29
2.6%
28 Jan 2019
van Deventer Sander Chief Scientific Officer
Sold, plan not stated
$42.52K 1,358 at 31.31
3.3%
28 Jan 2019
Sold, plan not stated
$37.90K 1,210 at 31.32
5.7%
28 Jan 2019
Sold, plan not stated
$37.90K 1,210 at 31.32
4.6%
28 Jan 2019
Sold, plan not stated
$37.90K 1,210 at 31.32
15.1%
28 Jan 2019
Kaye Jack Director
Sold, plan not stated
$37.89K 1,210 at 31.31
7.5%
28 Jan 2019
Sold, plan not stated
$37.89K 1,210 at 31.31
15.1%
28 Jan 2019
SCHAFFER DAVID Director
Sold, plan not stated
$37.89K 1,210 at 31.31
2.6%
28 Jan 2019
Kuta Alexander Edward III SVP, Regulatory Affairs
Sold, plan not stated
$32.92K 1,052 at 31.29
3.8%
Showing 201–250 of 272. ← Newer Page 5 of 6 Older →